Flare Reaction following Tarlatamab Treatment in a Patient with Extensive-Stage Small Cell Lung Cancer: Case Report
Our findings suggest that flare reaction occurs within days of initiating tarlatamab, possibly attributable to acute immune activation, as reported in BiTE therapies. Awareness of this possibility may help avoid premature discontinuation of effective treatment.
Authors
- Kazuya Ichikado (ORCID: https://orcid.org/0000-0002-4840-2450)
- Yoshihiko Sakata (ORCID: https://orcid.org/0000-0002-3300-9138)
- Kodai Kawamura (ORCID: https://orcid.org/0000-0002-6981-0648)
Institutions
- Saiseikai Kumamoto Hospital (JP)
Publication Details
- Journal
- Case Reports in Oncology
- Published
- 2025-12-18
- DOI
- https://doi.org/10.1159/000550082
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.05